Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for Uncomplicated Severe Acute Malnutrition
NCT03568643Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in severe acute malnutrition (SAM), sponsored by University of California, San Francisco. Started Jun 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
severe acute malnutrition (SAM)
Beyond the preview
Go deeper on NCT03568643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568643.